EcoDrugPlus

Ensembl ID : ENSCSEG00000011728
Gene Symbol: -
Cross references: -
381 Possible Orthologues:

Ensembl ID : ENSCSEG00000011726
Gene Symbol: -
Cross references: -
381 Possible Orthologues:

Ensembl ID : ENSCSEG00000011719
Gene Symbol: -
Cross references: -
381 Possible Orthologues:

Ensembl ID : ENSCSEG00000018802
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSCSEG00000007326
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSCSEG00000021646
Gene Symbol: -
Cross references: -
387 Possible Orthologues:

Ensembl ID : ENSCSEG00000017382
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSCSEG00000001947
Gene Symbol: -
Cross references: -
352 Possible Orthologues:

Ensembl ID : ENSCSEG00000006932
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSCSEG00000007432
Gene Symbol: -
Cross references: -
114 Possible Orthologues:

Ensembl ID : ENSCSEG00000001435
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSCSEG00000016925
Gene Symbol: -
Cross references: -
137 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).